Characterization of CD4+ CTLs Ex Vivo, The Journal of Immunology, vol.168, issue.11, pp.5954-5958, 2002. ,
DOI : 10.4049/jimmunol.168.11.5954
CD95-Mediated Tumor Recognition by CD4+ Effector Cells in a Murine Mammary Model, Journal of Immunotherapy, vol.23, issue.2, pp.225-234, 2000. ,
DOI : 10.1097/00002371-200003000-00007
IMGT/GeneInfo: enhancing V(D)J recombination database accessibility, Database issue), pp.32-51, 2004. ,
DOI : 10.1093/nar/gkh041
Complete molecular remissions induced by patient-specific vaccination plus granulocyte?monocyte colony-stimulating factor against lymphoma, Nature Medicine, vol.5, pp.1171-1177, 1999. ,
The standard ??2 test used in limiting dilution assays is insufficient for estimating the goodness-of-fit to the single-hit Poisson model, Journal of Immunological Methods, vol.167, issue.1-2, pp.21-33, 1994. ,
DOI : 10.1016/0022-1759(94)90071-X
Graphical Representation of a Generalized Linear Model-Based Statistical Test Estimating the Fit of the Single-Hit Poisson Model to Limiting Dilution Assays, The Journal of Immunology, vol.167, issue.10, pp.5725-5730, 2001. ,
DOI : 10.4049/jimmunol.167.10.5725
Terminal plasmocytoid differentiation of malignant B cells induced by autotumor-reactive CD4+ T cells in one case of splenic marginal zone B-cell lymphoma, Blood, vol.99, issue.1, pp.388-391, 2002. ,
DOI : 10.1182/blood.V99.1.388
T-Cell Receptor-Mediated Anergy of a Human Immunodeficiency Virus (HIV) gp120-Specific CD4+ Cytotoxic T-Cell Clone, Induced by a Natural HIV Type 1 Variant Peptide, Journal of Virology, vol.74, issue.5, pp.2121-2130, 2000. ,
DOI : 10.1128/JVI.74.5.2121-2130.2000
Accumulation of T-cell clones producing high levels of both granulocyte-macrophage and macrophage colony-stimulating factors (CSF-1) in lymph nodes involved by Hodgkin's disease, Leukemia, vol.6, pp.820-827, 1992. ,
Cancer Regression and Autoimmunity in Patients After Clonal Repopulation with Antitumor Lymphocytes, Science, vol.298, issue.5594, pp.850-854, 2002. ,
DOI : 10.1126/science.1076514
Adoptive Cell Transfer Therapy Following Non-Myeloablative but Lymphodepleting Chemotherapy for the Treatment of Patients With Refractory Metastatic Melanoma, Journal of Clinical Oncology, vol.23, issue.10, pp.2346-2357, 2005. ,
DOI : 10.1200/JCO.2005.00.240
Follicular Lymphoma Cell Lines, an In Vitro Model for Antigenic Selection and Cytokine-Mediated Growth Regulation of Germinal Centre B Cells, Scandinavian Journal of Immunology, vol.162, issue.6, pp.545-555, 2003. ,
DOI : 10.1146/annurev.immunol.16.1.293
Signaling Modulates Cytolytic T Lymphocyte Effector Functions, The Journal of Experimental Medicine, vol.156, issue.7, pp.1057-1067, 1998. ,
DOI : 10.1002/eji.1830260944
CD4+ Tregs and immune control, Journal of Clinical Investigation, vol.114, issue.9, pp.1209-1217, 2004. ,
DOI : 10.1172/JCI200423395
Tumor and CD4 T-cell interactions: tumor escape as result of reciprocal inactivation, Blood, vol.101, issue.11, pp.4472-4478, 2003. ,
DOI : 10.1182/blood-2002-10-3030
The Makings of a Tumor Rejection Antigen, Immunity, vol.11, issue.3, pp.263-270, 1999. ,
DOI : 10.1016/S1074-7613(00)80101-6
Opinion: The promise of cancer vaccines, Nature Reviews Cancer, vol.4, issue.5, pp.401-411, 2004. ,
DOI : 10.1038/nrc1359
NKT cells: facts, functions and fallacies, Immunology Today, vol.21, issue.11, pp.573-583, 2000. ,
DOI : 10.1016/S0167-5699(00)01735-7
Opinion: NKT cells: what's in a name?, Nature Reviews Immunology, vol.11, issue.3, pp.231-237, 2004. ,
DOI : 10.1038/nri1309
Immunity against cancer: lessons learned from melanoma, Current Opinion in Immunology, vol.13, issue.2, pp.134-140, 2001. ,
DOI : 10.1016/S0952-7915(00)00195-3
T Cells in the Antitumor Immune Response, The Journal of Experimental Medicine, vol.156, issue.12, pp.2357-2368, 1998. ,
DOI : 10.1084/jem.179.2.447
Participation of target Fas protein in apoptosis pathway induced by CD4+ Th1 and CD8+ cytotoxic T cells., Proceedings of the National Academy of Sciences of the United States of America, pp.4185-4189, 1994. ,
DOI : 10.1073/pnas.91.10.4185
Concanamycin A, a powerful tool for characterization and estimation of contribution of perforin-and Fas-based lytic pathways in cell-mediated cytotoxicity, Journal of Immunology, vol.156, pp.3678-3686, 1996. ,
Natural selection of tumor variants in the generation of ???tumor escape??? phenotypes, Nature Immunology, vol.3, issue.11, pp.999-1005, 2002. ,
DOI : 10.1038/ni1102-999
Impairment of death-inducing signalling complex formation in CD95-resistant human primary lymphoma B cells, British Journal of Haematology, vol.94, issue.6, pp.746-753, 2004. ,
DOI : 10.1074/jbc.274.3.1646
IMGT, the international ImMunoGeneTics database(R), Nucleic Acids Research, vol.31, issue.1, pp.307-310, 2003. ,
DOI : 10.1093/nar/gkg085
The regulation of CD95 ligand expression and function in CTL, Journal of Immunology, vol.161, pp.3943-3949, 1998. ,
Therapeutic effect of idiotype-specific CD4+ T cells against B-cell lymphoma in the absence of anti-idiotypic antibodies, Blood, vol.102, issue.2, pp.605-612, 2003. ,
DOI : 10.1182/blood-2002-11-3381
Role of autologous CD4+ T cell clones in human B non-Hodgkin's lymphoma: aborted activation and G1 blockade induced by cell-cell contact, European Journal of Immunology, vol.78, issue.10, pp.3188-3195, 1999. ,
DOI : 10.1002/(SICI)1521-4141(199910)29:10<3188::AID-IMMU3188>3.0.CO;2-D
Increased number of cytotoxic T cells within CD4+8??? T cells in ??2-microglobulin, major histocompatibility complex class I-deficient mice, European Journal of Immunology, vol.10, issue.12, pp.3115-3119, 1993. ,
DOI : 10.1002/eji.1830231211
Tumor-Specific CD4+ T Cells Have a Major "Post-Licensing" Role in CTL Mediated Anti-Tumor Immunity, The Journal of Immunology, vol.165, issue.11, pp.6047-6055, 2000. ,
DOI : 10.4049/jimmunol.165.11.6047
Immunotherapy of Cytotoxic T Cell???resistant Tumors by T Helper 2 Cells, The Journal of Experimental Medicine, vol.56, issue.3, pp.387-393, 2003. ,
DOI : 10.1056/NEJM199805283382206
Studies of the mechanism of cytolysis by HIV-1-specific CD4+ human CTL clones induced by candidate AIDS vaccines, Journal of Immunology, vol.153, pp.2787-2799, 1994. ,
CD4(+) T cells eliminate MHC class II-negative cancer cells in vivo by indirect effects of IFN-gamma, Proceedings of the National Academy of Sciences of the United States of America, pp.8633-8638, 1999. ,
Selective expression of a novel surface molecule by human Th2 cells in vivo, Journal of Immunology, vol.162, pp.1278-1286, 1999. ,
Cytolytic CD4+-T-Cell Clones Reactive to EBNA1 Inhibit Epstein-Barr Virus-Induced B-Cell Proliferation, Journal of Virology, vol.77, issue.22, pp.12088-12104, 2003. ,
DOI : 10.1128/JVI.77.22.12088-12104.2003
T-cell release of granulysin contributes to host defense in leprosy, Nature Medicine, vol.7, issue.2, pp.174-179, 2001. ,
DOI : 10.1038/84620
Fas-independent and nonapoptotic cytotoxicity mediated by a human CD4(+) T-cell clone directed against an acute myelogenous leukemia-associated DEK-CAN fusion peptide, Blood, vol.93, pp.925-935, 1999. ,
Importance of CD4+ T helper cell responses in tumor immunity, Immunology Letters, vol.74, issue.1, pp.75-79, 2000. ,
DOI : 10.1016/S0165-2478(00)00252-2
The role of CD4+ T cell responses in antitumor immunity, Current Opinion in Immunology, vol.10, issue.5, pp.588-594, 1998. ,
DOI : 10.1016/S0952-7915(98)80228-8
Quantitative and Qualitative Changes in V-J ?? Rearrangements During Mouse Thymocytes Differentiation, The Journal of Experimental Medicine, vol.144, issue.9, pp.1163-1173, 2002. ,
DOI : 10.1016/0167-5699(92)90044-8
Multiple targets for brefeldin A, Cell, vol.67, issue.3, pp.449-451, 1991. ,
DOI : 10.1016/0092-8674(91)90517-3
Malignant B lymphocytes from non-Hodgkin's lymphoma induce allogeneic proliferative and cytotoxic T cell responses in primary mixed lymphocyte cultures: an important role of co-stimulatory molecules CD80, ) in stimulation by tumor cells, pp.7-8, 1995. ,
Tumor B cells from non-Hodgkin's lymphoma are resistant to CD95 (Fas/Apo-1)-mediated apoptosis, Blood, vol.91, pp.2875-2885, 1998. ,
Oligoclonality of tumor-infiltrating lymphocytes from human melanomas, Journal of Immunology, vol.153, pp.2807-2818, 1994. ,
CD4+ T Cell???Mediated Tumor Rejection Involves Inhibition of Angiogenesis that Is Dependent on IFN?? Receptor Expression by Nonhematopoietic Cells, Immunity, vol.12, issue.6, pp.677-686, 2000. ,
DOI : 10.1016/S1074-7613(00)80218-6
CD95 (Fas)-dependent elimination of self-reactive B cells upon interaction with
CD4+T cells, Nature, vol.376, issue.6536, pp.181-184, 1995. ,
DOI : 10.1038/376181a0
The Role of Chemokine Receptors in Primary, Effector, and Memory Immune Responses, Annual Review of Immunology, vol.18, issue.1, pp.593-620, 2000. ,
DOI : 10.1146/annurev.immunol.18.1.593
Differential use of Fas ligand and perforin cytotoxic pathways by donor T cells in graft-versus-host disease and graft-versus-leukemia effect, Blood, vol.97, issue.9, pp.2886-2895, 2001. ,
DOI : 10.1182/blood.V97.9.2886
Functional Analysis of Tumor-Specific Th Cell Responses Detected in Melanoma Patients after Dendritic Cell-Based Immunotherapy, The Journal of Immunology, vol.172, issue.2, pp.1304-1310, 2004. ,
DOI : 10.4049/jimmunol.172.2.1304
Autotumour reactive T-cell clones among tumour-infiltrating T lymphocytes in B-cell non-Hodgkin's lymphomas, British Journal of Haematology, vol.10, issue.4, pp.837-843, 1995. ,
DOI : 10.1084/jem.169.5.1557
Cytokine production and cytolytic mechanism of CD4+ cytotoxic T lymphocytes in ex vivo expanded therapeutic Epstein-Barr virus-specific T-cell cultures, Blood, vol.99, issue.9, pp.3302-3309, 2002. ,
DOI : 10.1182/blood.V99.9.3302
VJ REARRANGEMENTS OF THE TCR?? LOCUS IN PERIPHERAL T-CELL LYMPHOMAS: ANALYSIS BY POLYMERASE CHAIN REACTION AND DENATURING GRADIENT GEL ELECTROPHORESIS, The Journal of Pathology, vol.316, issue.3, pp.303-310, 1996. ,
DOI : 10.1002/(SICI)1096-9896(199603)178:3<303::AID-PATH475>3.0.CO;2-I
Induction of proliferation of human follicular (B type) lymphoma cells by cognate interaction with CD4+ T cell clones, Journal of Immunology, vol.144, pp.2550-2557, 1990. ,
T lymphocytes infiltrating the liver during chronic hepatitis C infection express a broad range of T-cell receptor beta chain diversity, Journal of Hepatology, vol.38, issue.5, pp.651-659, 2003. ,
DOI : 10.1016/S0168-8278(03)00089-8
The role of MHC class II-restricted tumor antigens and CD4+ T cells in antitumor immunity, Trends in Immunology, vol.22, issue.5, pp.269-276, 2001. ,
DOI : 10.1016/S1471-4906(01)01896-8
Role of TRAIL and IFN-?? in CD4+ T Cell-Dependent Tumor Rejection in the Anterior Chamber of the Eye, The Journal of Immunology, vol.171, issue.6, pp.2789-2796, 2003. ,
DOI : 10.4049/jimmunol.171.6.2789
Identification of a population of CD4+ CTL that utilizes a perforin-rather than a Fas liganddependent cytotoxic mechanism, Journal of Immunology, vol.156, pp.153-159, 1996. ,
Essential Roles of Perforin in Antigen-Specific Cytotoxicity Mediated by Human CD4+ T Lymphocytes: Analysis Using the Combination of Hereditary Perforin-Deficient Effector Cells and Fas-Deficient Target Cells, The Journal of Immunology, vol.170, issue.4, pp.2205-2213, 2003. ,
DOI : 10.4049/jimmunol.170.4.2205
Intratumoral CD4+CD25+ regulatory T-cell-mediated suppression of infiltrating CD4+ T cells in B-cell non-Hodgkin lymphoma, Blood, vol.107, issue.9, pp.3639-3646, 2006. ,
DOI : 10.1182/blood-2005-08-3376
Expression of perforin and membrane-bound lymphotoxin (tumor necrosis factorbeta ) in virus-specific CD4+ human cytotoxic T-cell clones, Blood, vol.81, pp.1527-1534, 1993. ,
Adoptive T cell therapy using antigen-specific CD8+ T cell clones for the treatment of patients with metastatic melanoma: In vivo persistence, migration, and antitumor effect of transferred T cells, Proceedings of the National Academy of Sciences of the United States of America, pp.16168-16173, 2002. ,
DOI : 10.1002/(SICI)1097-0215(19970410)71:2<142::AID-IJC3>3.0.CO;2-0